Position in BMY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$49,911,796
+$7,728,667 QoQ
Shares Held
822,948
+5.2% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$6,065
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Cetera Investment Advisers holds $1,375,333,185 across 16 Drug Manufacturers - General names. BMY ranks #8 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
345,970 | $318,212,826 | |
| 2 | JNJ |
Johnson & Johnson
|
1,034,600 | $252,897,624 | |
| 3 | ABBV |
AbbVie Inc.
|
965,429 | $209,971,153 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,193,872 | $143,610,862 | |
| 5 | AMGN |
Amgen Inc
|
345,260 | $121,479,731 | |
| 6 | PFE |
Pfizer Inc
|
3,213,627 | $90,238,646 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
404,797 | $56,416,557 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
822,948 | $49,911,796 |
All Filings in BMY
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,065 | 100 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $49,911,796 | 822,948 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,394 | 100 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $42,183,129 | 782,038 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $5,394 | 100 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $35,591,386 | 789,166 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $9,020 | 200 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $4,629 | 100 | Call | Sole | 2025-08-08 | |
| 2025-06-30 | $27,438,628 | 592,755 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $40,358,973 | 661,731 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $36,012,261 | 636,709 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $147,056 | 2,600 | Put | Sole | 2025-02-14 | |
| 2024-09-30 | $30,313,379 | 585,879 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $22,766,995 | 548,206 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $31,165,059 | 574,683 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $8,142,845 | 158,699 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,070,345 | 139,048 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,593,509 | 165,653 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $12,167,717 | 175,555 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $6,931 | 100 | Put | Sole | 2023-05-15 | |
| 2022-12-31 | $7,195 | 100 | Put | Sole | 2023-02-14 | |
| 2022-12-31 | $12,050,257 | 167,481 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,026,464 | 98,839 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,323,312 | 147,056 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $12,001,531 | 164,337 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,968,330 | 159,877 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,359,182 | 141,274 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $10,228,404 | 153,074 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,239,580 | 146,358 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $9,900,918 | 159,615 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $1,132,547 | 18,785 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,140,484 | 19,396 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,059,505 | 19,008 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||